XETR
MED
Market cap274mUSD
Oct 09, Last price
5.15EUR
1D
1.98%
1Q
27.48%
Jan 2017
-12.27%
IPO
-53.44%
Name
Mediclin AG
Chart & performance
P/E
9.60
P/S
0.31
EPS
0.54
Div yield, %
0.78%
Shrs. gr., 5y
—
Rev. gr., 5y
3.52%
Revenues
784m
+4.77%
Net income
25m
+2.61%
CFO
100m
+23.96%
Dividend
May 29, 20260.04 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Mediclin AG is a German healthcare enterprise primarily engaged in managing hospitals across the nation. Its operations are categorized into three main segments: Post-Acute, Acute, and various other related activities. The company offers a comprehensive range of medical specializations, encompassing fields such as neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, and surgical interventions, in addition to general nursing care. Furthermore, Mediclin provides specialized services like ear, nose, and throat (ENT) treatment and acute outpatient care. As of December 31, 2021, its extensive network comprised 34 clinics, 7 nursing care facilities, and 11 medical care centres. This infrastructure collectively provided a significant capacity of 7,831 beds and 482 nursing places, distributed across eleven of Germany's federal states. The company's corporate headquarters are situated in Offenburg, Germany.
Related entities
Parent (2)
Asklepios Kliniken GmbH & Co. KGaA
Broermann Holding GmbH
Subsidiaries
MediClin GmbH & Co. KG
Key people
Chairman of the Supervisory Board · since 2012
Volker Hippler
Chairman of the Management Board · since 2016
Hans Hilpert
Vice Chairman of the Supervisory Board, Employee Representative · since 2002
Tino Fritz
Chief Financial Officer, Member of the Management Board · since 2018
Michael Bock
Member of the Supervisory Board · since 2005
Barbara Brosius
Member of the Supervisory Board · since 2017
Walburga Erichsmeier
Member of the Supervisory Board, Employee Representative · since 2012
Tom Giesler
Member of the Supervisory Board, Employee Representative · since 2012
Bernard grosse Broermann
Member of the Supervisory Board · since 2015
Rainer Laufs
Member of the Supervisory Board · since 2014
Eleonore Seigel
Member of the Supervisory Board, Employee Representative · since 2012
Matthias H. Werner
Member of the Supervisory Board, Employee Representative
Cornelia Wolf
Member of the Supervisory Board · since 2016
Headquarters & legal address
Okenstraße 27
Offenburg, BW 77652
DE
Offenburg, BW 77652
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||